Literature DB >> 1084818

Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function.

A S Fauci.   

Abstract

The present study was undertaken to determine what, if any, differential effect various commonly used corticosteroid preparations had on the numbers and specific functions of lymphocyte subpopulations when these agents were administered in equivalent pharmacological dosages. Normal volunteers received a single dose of either 320 mg of hydrocortisone intravenously, 80 mg of prednisone orally, or 12 mg of dexamethasone orally. There was a marked lymphocytopenia and monocytopenia maximal 4-6 hr following administration of all three corticosteroid preparations with almost identical kinetics and degree of fall in total cell numbers as well as proportions of thymus-derived and bone marrow-derived lymphocytes. Hydrocortisone and prednisone caused only a slight suppression of phytohaemagglutiinin (PHA) induced lymphocyte blastogensis which could be reversed at supra-optimal concentrations of PHA. On the contrary, dexamethasone administration casued a marked suppression of PHA responses which was not reversed by supra-optimal PHA stimulation. In addition, hydrocortisone and prednisone administration did not suppress non-specific PHA-induced cellular cytotoxcity, while dexamethasone caused a marked suppression (P less than 0.001) of cytotoxicity. These studies show that although equivalent anti-inflammatory doses of these three corticosteroid preparations cause almost identical suppression of the numbers of circulating lymphocyte populations, they have a differential effect of the numbers of circulating lymphocyte populations, they have a differential effect on a certain in vitro functional correlates of cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084818      PMCID: PMC1538503     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  ANTI-INFLAMMATORY STEROIDS: POTENCY, DURATION AND MODIFICATION OF ACTIVITIES.

Authors:  L J LERNER; A BIANCHI; A R TURKHEIMER; F M SINGER; A BORMAN
Journal:  Ann N Y Acad Sci       Date:  1964-08-27       Impact factor: 5.691

2.  THE EFFECT OF ADRENAL GLUCOCORTICOSTEROIDS UPON THE CELLULAR COMPOSITION OF INFLAMMATORY EXUDATES.

Authors:  D R BOGGS; J W ATHENS; G E CARTWRIGHT; M M WINTROBE
Journal:  Am J Pathol       Date:  1964-05       Impact factor: 4.307

3.  Clinical pharmacology of the anti-inflammatory steroids.

Authors:  G W LIDDLE
Journal:  Clin Pharmacol Ther       Date:  1961 Sep-Oct       Impact factor: 6.875

4.  Interruption by topical cortisone of leukocytic cycles in acute inflammation in man.

Authors:  J W REBUCK; R C MELLINGER
Journal:  Ann N Y Acad Sci       Date:  1953-07-17       Impact factor: 5.691

5.  Clinical considerations in the use of corticosteroids.

Authors:  G W Thorn
Journal:  N Engl J Med       Date:  1966-04-07       Impact factor: 91.245

Review 6.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

7.  Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).

Authors:  G Sherwood; R M Blaese
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

8.  Acute myocardial infarction due to childhood lymphoma.

Authors:  G C Bagby; R D Goldman; H C Newman; J F Means
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  36 in total

1.  Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers.

Authors:  H Derendorf; H Möllmann; M Krieg; S Tunn; C Möllmann; J Barth; H J Röthig
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

2.  Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation.

Authors:  O Kanemi; X Zhang; Y Sakamoto; M Ebina; R Nagatomi
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

Review 3.  Overtraining in athletes. An update.

Authors:  R W Fry; A R Morton; D Keast
Journal:  Sports Med       Date:  1991-07       Impact factor: 11.136

4.  Short-term neurophysiological monitoring in multiple sclerosis bouts. Evaluation of steroid treatment.

Authors:  V Scaioli; C Milanese; A Salmaggi; L LaMantia; A Campi; M Eoli; F Panzica
Journal:  Ital J Neurol Sci       Date:  1992-03

5.  The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.

Authors:  Lauren C Daniel; Yimei Li; Jacqueline D Kloss; Anne F Reilly; Lamia P Barakat
Journal:  Support Care Cancer       Date:  2016-04-23       Impact factor: 3.603

Review 6.  The leucocytosis of exercise. A review and model.

Authors:  D A McCarthy; M M Dale
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 7.  Overtraining in elite athletes. Review and directions for the future.

Authors:  H Kuipers; H A Keizer
Journal:  Sports Med       Date:  1988-08       Impact factor: 11.136

Review 8.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

9.  Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; A Ruíz-Argüelles
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.

Authors:  Roshan Ramanathan; Alice K Pau; Kristin H Busse; Marina Zemskova; Lynnette Nieman; Richard Kwan; Jean H Hammer; JoAnn M Mican; Frank Maldarelli
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.